Tumor necrosis factor-α attenuates starvation-induced apoptosis through upregulation of ferritin heavy chain in hepatocellular carcinoma cells

BMC Cancer

Volumn 13, Issue , 2013, Pages

  Kou, Xingrui ^a   Jing, Yingying ^a   Deng, Weijie ^a   Sun, Kai ^a,b   Han, Zhipeng ^a   Ye, Fei ^a   Yu, Guofeng ^a   Fan, Qingmin ^a   Gao, Lu ^a   Zhao, Qiudong ^a   Zhao, Xue ^b   Li, Rong ^a   Wei, Lixin ^a   Wu, Mengchao ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

^b SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Autophagy; Ferritin heavy chain; Hepatocellular carcinoma; NF B; Starvation; TNF

Indexed keywords

3 (4 METHYLPHENYLSULFONYL) 2 PROPENENITRILE; 3 METHYLADENINE; CASPASE; FERRITIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; REACTIVE OXYGEN METABOLITE; TUMOR NECROSIS FACTOR ALPHA;

APOPTOSIS; ARTICLE; ATTENUATION; AUTOPHAGY; BIOACCUMULATION; CELL DEATH; CELL VIABILITY; CONTROLLED STUDY; ENZYME INHIBITION; ENZYME REPRESSION; HUMAN; HUMAN CELL; LIVER CELL CARCINOMA; MOLECULAR MECHANICS; PROTEIN BLOOD LEVEL; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; TRANSACTIVATION; UPREGULATION;

ADENINE; APOFERRITINS; APOPTOSIS; CARCINOMA, HEPATOCELLULAR; CELL LINE, TUMOR; ENZYME ACTIVATION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LIVER NEOPLASMS; NF-KAPPA B; REACTIVE OXYGEN SPECIES; SIGNAL TRANSDUCTION; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84884515679     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-13-438     Document Type: Article

References (43)

1. Egberts JH, Cloosters V, Noack A, Schniewind B, Thon L, Klose S, et al. Anti-tumor necrosis factor therapy inhibits pancreatic tumor growth and metastasis. Cancer Res 2008, 68:1443-1450. 10.1158/0008-5472.CAN-07-5704, 18316608.
2. Luo JL, Maeda S, Hsu LC, Yagita H, Karin M. Inhibition of NF-kappaB in cancer cells converts inflammation-induced tumor growth mediated by TNF-alpha to TRAIL-mediated tumor regression. Cancer Cell 2004, 6:297-305. 10.1016/j.ccr.2004.08.012, 15380520.
3. Wang AM, Creasey AA, Ladner MB, Lin LS, Strickler J, Van Arsdell JN, et al. Molecular cloning of the complementary DNA for human tumor necrosis factor. Science 1985, 228:149-154. 10.1126/science.3856324, 3856324.
4. van Horssen R, Ten Hagen TL, Eggermont AM. TNF-alpha in cancer treatment: molecular insights, antitumor effects, and clinical utility. Oncologist 2006, 11:397-408. 10.1634/theoncologist.11-4-397, 16614236.
5. Benedetti G, Fredriksson L, Herpers B, Meerman J, van de Water B, de Graauw M. TNF-alpha-mediated NF-kappaB survival signaling impairment by cisplatin enhances JNK activation allowing synergistic apoptosis of renal proximal tubular cells. Biochem Pharmacol 2013, 85:274-286. 10.1016/j.bcp.2012.10.012, 23103562.
6. Lovas A, Weidemann A, Albrecht D, Wiechert L, Weih D, Weih F. p100 Deficiency is insufficient for full activation of the alternative NF-kappaB pathway: TNF cooperates with p52-RelB in target gene transcription. PLoS One 2012, 7:e42741. 10.1371/journal.pone.0042741, 3412832, 22880094.
7. Baeuerle PA, Baltimore D. NF-kappa B: ten years after. Cell 1996, 87:13-20. 10.1016/S0092-8674(00)81318-5, 8858144.
8. Mayo MW, Baldwin AS. The transcription factor NF-kappaB: control of oncogenesis and cancer therapy resistance. Biochim Biophys Acta 2000, 1470:M55-M62.
9. Liu ZG, Hsu H, Goeddel DV, Karin M. Dissection of TNF receptor 1 effector functions: JNK activation is not linked to apoptosis while NF-kappaB activation prevents cell death. Cell 1996, 87:565-576. 10.1016/S0092-8674(00)81375-6, 8898208.
10. Zhang J, Cado D, Chen A, Kabra NH, Winoto A. Fas-mediated apoptosis and activation-induced T-cell proliferation are defective in mice lacking FADD/Mort1. Nature 1998, 392:296-300. 10.1038/32681, 9521326.
11. Wang CY, Mayo MW, Korneluk RG, Goeddel DV, Baldwin AS. NF-κB antiapoptosis: induction of TRAF1 and TRAF2 and c-IAP1 and c-IAP2 to suppress caspase-8 activation. Science 1998, 281:1680-1683.
12. Roperto S, Borzacchiello G, Brun R, Costanzo F, Faniello MC, Raso C, et al. Ferritin heavy chain (FHC) is Up-regulated in papillomavirus-associated urothelial tumours of the urinary bladder in cattle. J Comp Pathol 2010, 142:9-18. 10.1016/j.jcpa.2009.05.009, 19596355.
13. Bubici C, Papa S, Pham CG, Zazzeroni F, Franzoso G. NF-kappaB and JNK: an intricate affair. Cell Cycle 2004, 3:1524-1529. 10.4161/cc.3.12.1321, 15611622.
14. Jing YY, Han ZP, Sun K, Zhang SS, Hou J, Liu Y, et al. Toll-like receptor 4 signaling promotes epithelial-mesenchymal transition in human hepatocellular carcinoma induced by lipopolysaccharide. BMC Med 2012, 10:98. 10.1186/1741-7015-10-98, 3482562, 22938142.
15. Qin Y, Camoretti-Mercado B, Blokh L, Long CG, Ko FD, Hamann KJ. Fas resistance of leukemic eosinophils is due to activation of NF-κB by Fas ligation. J Immunol 2002, 169:3536-3544.
16. Kelliher MA, Grimm S, Ishida Y, Kuo F, Stanger BZ, Leder P. The death domain kinase RIP mediates the TNF-induced NF-κB signal. Immunity 1998, 8:297-303. 10.1016/S1074-7613(00)80535-X, 9529147.
17. Yeh WC, Shahinian A, Speiser D, Kraunus J, Billia F, Wakeham A, et al. Early lethality, functional NF-κB activation, and increased sensitivity to TNF-induced cell death in TRAF2-deficient mice. Immunity 1997, 7:715-725. 10.1016/S1074-7613(00)80391-X, 9390694.
18. Colleran A, Ryan A, O'Gorman A, Mureau C, Liptrot C, Dockery P, et al. Autophagosomal IkappaB alpha degradation plays a role in the long term control of tumor necrosis factor-alpha-induced nuclear factor-kappaB (NF-kappaB) activity. J Biol Chem 2011, 286:22886-22893. 10.1074/jbc.M110.199950, 3123056, 21454695.
19. Notarbartolo M, Poma P, Perri D, Dusonchet L, Cervello M, D'Alessandro N. Antitumor effects of curcumin, alone or in combination with cisplatin or doxorubicin, on human hepatic cancer cells. Analysis of their possible relationship to changes in NF-kB activation levels and in IAP gene expression. Cancer Lett 2005, 224:53-65. 10.1016/j.canlet.2004.10.051, 15911101.
20. You M, Ku PT, Hrdlicková R, Bose HR. ch-IAP1, a member of the inhibitor-of-apoptosis protein family, is a mediator of the antiapoptotic activity of the v-Rel oncoprotein. Mol Cell Biol 1997, 17:7328-7341. 232589, 9372964.
21. Catz SD, Johnson JL. Transcriptional regulation of bcl-2 by nuclear factor kappa B and its significance in prostate cancer. Oncogene 2001, 20:7342-7351. 10.1038/sj.onc.1204926, 11704864.
22. Hao XS, Hao JH, Liu FT, Newland AC, Jia L. Potential mechanisms of leukemia cell resistance to TRAIL-induced apopotosis. Apoptosis 2003, 8:601-607.
23. LaCasse EC, Baird S, Korneluk RG, MacKenzie AE. The inhibitors of apoptosis (IAPs) and their emerging role in cancer. Oncogene 1998, 17:3247-3259.
24. Mattson MP, Meffert MK. Roles for NF-κB in nerve cell survival, plasticity, and disease. Cell Death & Differentiation 2006, 13:852-860. 10.1038/sj.cdd.4401837, 24073380.
25. Schwenzer R, Siemienski K, Liptay S, Schubert G, Peters N, Scheurich P, et al. The human tumor necrosis factor (TNF) receptor-associated factor 1 gene (TRAF1) is up-regulated by cytokines of the TNF ligand family and modulates TNF-induced activation of NF-κB and c-Jun N-terminal kinase. J Biol Chem 1999, 274:19368-19374. 10.1074/jbc.274.27.19368, 10383449.
26. Pham CG, Bubici C, Zazzeroni F, Papa S, Jones J, Alvarez K. Ferritin heavy chain upregulation by NF-κB inhibits TNFα-induced apoptosis by suppressing reactive oxygen species. Cell 2004, 119:529-542. 10.1016/j.cell.2004.10.017, 15537542.
27. Ding WX, Yin XM. Dissection of the multiple mechanisms of TNF-α-induced apoptosis in liver injury. J Cell Mol Med 2004, 8:445-454. 10.1111/j.1582-4934.2004.tb00469.x, 15601573.
28. Balkwill F. Cancer and the chemokine network. Nat Rev Cancer 2004, 4:540-550. 10.1038/nrc1388, 15229479.
29. Bertazza L, Mocellin S. The dual role of tumor necrosis factor (TNF) in cancer biology. Curr Med Chem 2010, 17:3337-3352. 10.2174/092986710793176339, 20712570.
30. Liu RY, Fan C, Liu G, Olashaw NE, Zuckerman KS. Activation of p38 mitogen-activated protein kinase is required for tumor necrosis factor-alpha -supported proliferation of leukemia and lymphoma cell lines. J Biol Chem 2000, 275:21086-21093. 10.1074/jbc.M001281200, 10783388.
31. Katerinaki E, Evans GS, Lorigan PC, MacNeil S. TNF-alpha increases human melanoma cell invasion and migration in vitro: the role of proteolytic enzymes. Br J Cancer 2003, 89:1123-1129. 10.1038/sj.bjc.6601257, 2376936, 12966436.
32. Nabors LB, Suswam E, Huang Y, Yang X, Johnson MJ, King PH. Tumor necrosis factor alpha induces angiogenic factor up-regulation in malignant glioma cells: a role for RNA stabilization and HuR. Cancer Res 2003, 63:4181-4187.
33. Knight B, Yeoh GC, Husk KL, Ly T, Abraham LJ, Yu C, et al. Impaired preneoplastic changes and liver tumor formation in tumor necrosis factor receptor type 1 knockout mice. J Exp Med 2000, 192:1809-1818. 10.1084/jem.192.12.1809, 2213505, 11120777.
34. Pikarsky E, Porat RM, Stein I, Abramovitch R, Amit S, Kasem S, et al. NF-κB functions as a tumour promoter in inflammation-associated cancer. Nature 2004, 431:461-466. 10.1038/nature02924, 15329734.
35. Degenhardt K, Mathew R, Beaudoin B, Bray K, Anderson D, Chen G, et al. Autophagy promotes tumor cell survival and restricts necrosis, inflammation, and tumorigenesis. Cancer Cell 2006, 10:51-64. 10.1016/j.ccr.2006.06.001, 2857533, 16843265.
36. Kimmelman AC. The dynamic nature of autophagy in cancer. Genes Dev 2011, 25:1999-2010. 10.1101/gad.17558811, 3197199, 21979913.
37. Kroemer G, Mariño G, Levine B. Autophagy and the integrated stress response. Mol Cell 2010, 40:280-293. 10.1016/j.molcel.2010.09.023, 3127250, 20965422.
38. Maiuri MC, Tasdemir E, Criollo A, Morselli E, Vicencio JM, Carnuccio R, et al. Control of autophagy by oncogenes and tumor suppressor genes. Cell Death Differ 2008, 16:87-93.
39. Comb WC, Cogswell P, Sitcheran R, Baldwin AS. IKK-dependent, NF-kappaB-independent control of autophagic gene expression. Oncogene 2011, 30:1727-1732. 10.1038/onc.2010.553, 3369814, 21151171.
40. Criollo A, Senovilla L, Authier H, Maiuri MC, Morselli E, Vitale I, et al. The IKK complex contributes to the induction of autophagy. EMBO J 2010, 29:619-631. 10.1038/emboj.2009.364, 2830700, 19959994.
41. Bubici C, Papa S, Pham CG, Zazzeroni F, Franzoso G. The NF-kappaB-mediated control of ROS and JNK signaling. Histol Histopathol 2006, 21:69-80.
42. Torti FM, Torti SV. Regulation of ferritin genes and protein. Blood 2002, 99:3505-3516. 10.1182/blood.V99.10.3505, 11986201.
43. Aung W, Hasegawa S, Furukawa T, Saga T. Potential role of ferritin heavy chain in oxidative stress and apoptosis in human mesothelial and mesothelioma cells: implications for asbestos-induced oncogenesis. Carcinogenesis 2007, 28:2047-2052. 10.1093/carcin/bgm090, 17434931.